Independently assess launches and benchmark history of analogs.
Launch Dynamix™ provides granular tracking & benchmarking of brands for the first 18 months.
- Monthly benchmarking of newly launched products (first 18 months)
- Augmented by a quarterly deep dive into:
- Promotional activity
- Barriers to uptake
- Patient types gravitating to the launch brand
Methodology:
- Insights are based on analyses of quantitative data from an online survey of physicians recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents.
Sample Size & Frequency:
- Monthly KPI benchmarking (n=75 physicians)
- Quarterly report (n=75 physicians)
- Quarterly qualitative interviews (n=8 physicians)
Reveal the ‘why’ behind treatment decisions and understand the patient journey.
Patient Chart Dynamix™ audits help you develop patient profiles and uncover opportunities.
- Capture data not available in claims by tapping into rigorous analysis of large-scale patient chart audits
- Understand differences between stated and actual treatment patterns with Specialists’ attitudinal & demographic data
- See how clinical trial populations compare to real patient management patterns and identify secondary endpoints that will allow for differentiation
Methodology:
- Insights are based on patient-level data gathered through collaboration with specialty physicians who provide details on clinical and non-clinical patient demographics, along with rationale for treatment choices.
Sample Size & Frequency:
- (sample sizes may vary based on inclusion criteria)
- US Annual Report (n=1,000 charts, n=200 physicians)
- EU5 Annual Report (n=1,250 charts, n=250 physicians)
Understand the prescriber’s perspective of the competitive landscape.
RealTime Dynamix™ delivers robust, unbiased brand and class trending of KPIs.
- See the market from the prescriber’s point of view
- Market trending, core rotational content, and event-driven & variable content with each wave, exploring:
- Brand use, intentions, promotional activity
- Disease awareness, controversy
- Pipeline product perceptions
Methodology:
- Insights based on data from an online survey of respondents recruited from the Spherix Network, a proprietary group of screened practicing specialty physicians.
Sample Size & Frequency:
- US: quarterly report (n=100-200 respondents)
- EU5: semiannual report (n=250 respondents)
- Canada: semiannual report (n=50 respondents)
Add context to trending topics and gauge the impact of disruptive events.
Special Topix™ reports on trending events and topics of interest in specialty markets.
- Gain an objective perspective and context into the real issues influencing market shifts
- Understand the prescriber’s perspective on trending topics and disruptive events
- Gather insights on initial and potential lasting impacts on existing commercial brands
- Deep dive into the mindset of fellows & residents
Methodology:
- Insights are based on data from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.
Sample Size & Frequency:
- Report cadence and deliverable depend upon current event/topic.
